Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine for Cognitive Enhancement in Down Syndrome
NCT02304302Phase 2Completed
- Sponsor
- University Hospitals Cleveland Medical Center
- Start
- Oct 2014
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of memantine in Down syndrome, sponsored by University Hospitals Cleveland Medical Center. Started Oct 2014; status: completed.
02
Drugs
memantine
03
Conditions
Down syndrome
Beyond the preview
Go deeper on NCT02304302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02304302.